BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25539755)

  • 1. [What's new in skin cancers?].
    Jouary T
    Ann Dermatol Venereol; 2014 Dec; 141 Suppl 4():S630-42. PubMed ID: 25539755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What's new in oncodermatology?].
    Lebbé C
    Ann Dermatol Venereol; 2017 Dec; 144 Suppl 4():IVS40-IVS46. PubMed ID: 29249251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [What's new in oncology?].
    Dalle S
    Ann Dermatol Venereol; 2012 Dec; 139 Suppl 5():S217-22. PubMed ID: 23522708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What’s new in dermato-oncology?].
    Quéreux G
    Ann Dermatol Venereol; 2013 Nov; 140 Suppl 3():S283-92. PubMed ID: 24365500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and planned multicenter trials for patients with primary or metastatic melanoma.
    Sondak VK; Han D; Deneve J; Kudchadkar R
    J Surg Oncol; 2011 Sep; 104(4):430-7. PubMed ID: 21858839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Melanoma update].
    Longvert C; Saiag P
    Rev Med Interne; 2019 Mar; 40(3):178-183. PubMed ID: 30527396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What's new in dermato-oncology?].
    Basset-Séguin N
    Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S253-62. PubMed ID: 22202647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Advances and Treatment Options in Metastatic Melanoma.
    Johnson DB; Sosman JA
    JAMA Oncol; 2015 Jun; 1(3):380-6. PubMed ID: 26181188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous melanoma.
    Eggermont AM; Spatz A; Robert C
    Lancet; 2014 Mar; 383(9919):816-27. PubMed ID: 24054424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].
    Leccia MT; Planchamp F; Sassolas B; Combemale P; Modiano P; Bedane C; Cupissol D; Derrey S; Dygai-Cochet I; Lamant L; Lubrano V; Mirabel X; Mourrégot A; Rougé Bugat ME; Siegrist S; Thariat J; Tiffet O; Truc G; Verdoni L; Mazeau-Woynar V
    Ann Dermatol Venereol; 2014 Feb; 141(2):111-21. PubMed ID: 24507205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What's new in oncodermatology?].
    Bagot M
    Ann Dermatol Venereol; 2009 Dec; 136 Suppl 7():S436-44. PubMed ID: 20110059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management.
    Hwang SJ; Anforth R; Carlos G; Fernandez-Peñas P
    Actas Dermosifiliogr; 2017; 108(1):6-16. PubMed ID: 27642030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of melanoma.
    Corrie P; Hategan M; Fife K; Parkinson C
    Br Med Bull; 2014 Sep; 111(1):149-62. PubMed ID: 25190764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Skin cancer: what's new in clinical research?].
    Grange F
    Ann Dermatol Venereol; 2007 Dec; 134 Suppl 1():8S53-63. PubMed ID: 18675141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What's new in oncodermatology?].
    Robert C
    Ann Dermatol Venereol; 2018 Dec; 145 Suppl 7():VIIS40-VIIS46. PubMed ID: 30583756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rapidly evolving therapies for advanced melanoma--Towards immunotherapy, molecular targeted therapy, and beyond.
    Zhu Z; Liu W; Gotlieb V
    Crit Rev Oncol Hematol; 2016 Mar; 99():91-9. PubMed ID: 26708040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Innovative therapies for metastatic melanoma in elderly patients].
    Du-Thanh A; Lesage C; Ferreira E; Dereure O; Guillot B
    Ann Dermatol Venereol; 2015 Oct; 142(10):549-56. PubMed ID: 25986740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New breakthroughs in Oncodermatology].
    Mortier L
    Ann Dermatol Venereol; 2010 Dec; 137 Suppl 4():S158-64. PubMed ID: 21193119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
    Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D; ;
    J Dtsch Dermatol Ges; 2013 Aug; 11 Suppl 6():1-116, 1-126. PubMed ID: 24028775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (Neo)adjuvant systemic therapy for melanoma.
    van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
    Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.